发布求助
文献互助 智能选刊 最新文献

Therapeutic radiology and oncology最新文献

筛选
英文 中文
Adjuvant radiotherapy for dermatofibrosarcoma protuberans: a case report 隆突性皮肤纤维肉瘤的辅助放射治疗1例
Therapeutic radiology and oncology Pub Date : 2019-02-09 DOI: 10.21037/tro.2019.08.01
Mingfu Hu, S. Kuo
{"title":"Adjuvant radiotherapy for dermatofibrosarcoma protuberans: a case report","authors":"Mingfu Hu, S. Kuo","doi":"10.21037/tro.2019.08.01","DOIUrl":"https://doi.org/10.21037/tro.2019.08.01","url":null,"abstract":"Dermatofibrosarcoma protuberans (DFSP) is a rare and slowly growing tumor. Inadequate surgical resection is associated with a high recurrence rate. However, complete resection with wide margins in some cases may cause cosmetic or functional deficits. Previous studies suggest that adjuvant radiotherapy (RT) can effectively decrease the local recurrence rate. We report the case of a tumor in the right shoulder of a 25-year-old woman, in which the tumor was located adjacent to the skin and joint. She underwent wide excision of this tumor, and the pathologic findings of this tumor showed DFSP with close margins. She was subsequently administered intensity modulated radiation therapy (IMRT) of 46 Gy with 2 Gy per fraction for the tumor bed and wide margins followed by 14 Gy with 2 Gy per fraction for the tumor bed boost. She remained disease-free during the 3-year follow-up. This finding indicates that adjuvant RT is considered for patients with DFSP who have close margins or in whom wide surgical margins are not feasible.","PeriodicalId":93236,"journal":{"name":"Therapeutic radiology and oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/tro.2019.08.01","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48092459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of current perspectives on low-energy X-ray intraoperative radiotherapy in early stage breast cancer 早期乳腺癌术中低能x线放疗研究进展综述
Therapeutic radiology and oncology Pub Date : 2019-01-04 DOI: 10.21037/tro.2019.01.03
Yang-Hong Dai, Yu-Jen Chen, Chun-Shu Lin, Kuen‐Tze Lin, Wen-Yen Huang, Chang-Ming Chen, Yu-Fu Su, Chao-Yueh Fan, C. Lo, Yen-Fu Yang, C. Tsao, Ming-Yueh Liu, P. Shen, H. Chao, K. Chao
{"title":"Review of current perspectives on low-energy X-ray intraoperative radiotherapy in early stage breast cancer","authors":"Yang-Hong Dai, Yu-Jen Chen, Chun-Shu Lin, Kuen‐Tze Lin, Wen-Yen Huang, Chang-Ming Chen, Yu-Fu Su, Chao-Yueh Fan, C. Lo, Yen-Fu Yang, C. Tsao, Ming-Yueh Liu, P. Shen, H. Chao, K. Chao","doi":"10.21037/tro.2019.01.03","DOIUrl":"https://doi.org/10.21037/tro.2019.01.03","url":null,"abstract":"In early stage breast cancer, intraoperative radiation therapy (IORT) is a form of accelerated partial breast irradiation (APBI) that provides attractive therapeutic effects while shortening the overall treatment time and sparing the normal tissue radiation exposure. This technique has been used in Taiwan for several years in selected patients with breast cancer. However, some randomized trials pointed out that IORT is associated with higher rate of recurrence, therefore impeding its wider use as one of the standard managements in breast cancer. Also, despite its theoretical benefits for smaller tumor after surgery, the problem of recurrence warrants the necessity of strict and careful patient selection. The purpose of this article is to comprehensively review the updated consensus and current opinions on the use of IORT for early stage breast cancer.","PeriodicalId":93236,"journal":{"name":"Therapeutic radiology and oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/tro.2019.01.03","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45585853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Stereotactic radiotherapy in previously treated lung cancers—what are the risks? 立体定向放射治疗先前治疗过的肺癌-有什么风险?
Therapeutic radiology and oncology Pub Date : 2019-01-04 DOI: 10.21037/TRO.2019.03.02
A. Filippi, A. Lancia, M. Trovò
{"title":"Stereotactic radiotherapy in previously treated lung cancers—what are the risks?","authors":"A. Filippi, A. Lancia, M. Trovò","doi":"10.21037/TRO.2019.03.02","DOIUrl":"https://doi.org/10.21037/TRO.2019.03.02","url":null,"abstract":"Patients affected by intra-thoracic recurrences of primary or secondary lung malignancies after the first course of definitive radiotherapy (RT) have limited therapeutic options, and they are often treated with palliative intent. Re-irradiation with stereotactic radiotherapy (SRT) represents an appealing approach, due to the optimized dose distribution that allows for high-dose delivery with better sparing of organs at risk; however, toxicity still represents an issue, even with dose-fractionation risk-adapted approaches. This review aims to analyze clinical data and dosimetric parameters related to stereotactic re-irradiation, mainly focusing on the toxicity profile, whose risk often limits the adoption of this technique in clinical practice.","PeriodicalId":93236,"journal":{"name":"Therapeutic radiology and oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/TRO.2019.03.02","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45392790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comparing treatment plans for proximal and middle/distal stomach cancer: intensity-modulated radiotherapy, volumetric-modulated arc therapy, and tomotherapy 癌症近端和中端/远端治疗方案的比较：强度调制放疗、容量调制电弧治疗和断层治疗
Therapeutic radiology and oncology Pub Date : 2019-01-01 DOI: 10.21037/TRO.2018.12.05
Yun-Chih Chen, Jang-Chun Lin, Wei-Hsiu Liu, Sheng Huang, Y. Chou, Ming‐Hsien Li, J. Tsai
{"title":"Comparing treatment plans for proximal and middle/distal stomach cancer: intensity-modulated radiotherapy, volumetric-modulated arc therapy, and tomotherapy","authors":"Yun-Chih Chen, Jang-Chun Lin, Wei-Hsiu Liu, Sheng Huang, Y. Chou, Ming‐Hsien Li, J. Tsai","doi":"10.21037/TRO.2018.12.05","DOIUrl":"https://doi.org/10.21037/TRO.2018.12.05","url":null,"abstract":"Background: Adjuvant chemoradiotherapy is viewedas a definitive treatment after resection of stomach cancer (SC). To protectnormal tissue, several highly conformal radiotherapy modalities evolved.Therefore, we aimed to compare dosimetric parameters of helical tomotherapy(TOMO), volumetric-modulated arc therapy (VMAT), and intensity-modulatedradiotherapy (IMRT) in the adjuvant treatment of SC in different locations. Methods: This retrospective study wasconducted from January 2013 to May 2017 and included 11 patients with gastriccancer receiving adjuvant chemoradiotherapy after total gastrectomy. Both IMRTand VMAT plans were generated on the Pinnacle treatment planning system andTOMO plans were generated using a helical tomotherapy system. Adjuvantradiotherapy was prescribed with a total radiation dose of 50.4 Gy in 28fractions. Results: In proximal SC, TOMO achieved asignificantly lower dose for the heart, total kidney, left kidney, and liverthan that of IMRT or VMAT (P<0.05). In middle/distal SC, lower total kidneymean dose and V20 were observed with TOMO compared with IMRT (P=0.010 and0.011, respectively) and VMAT (P=0.049; P=0.014). Conclusions: For the adjuvant treatment of gastriccancer, TOMO not only provided superior dose sparing for total kidney, leftkidney, liver V 20 and liver V 30 in patients with proximalgastric cancer but also significantly lowered the heart dose in proximal SCwhen compared to IMRT or VMAT plan.","PeriodicalId":93236,"journal":{"name":"Therapeutic radiology and oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/TRO.2018.12.05","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49611778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical considerations of lung stereotactic ablative radiotherapy in the developing world 发展中国家肺立体定向消融放疗的实践思考
Therapeutic radiology and oncology Pub Date : 2019-01-01 DOI: 10.21037/TRO.2018.12.10
D. Asher, P. Munoz-Schuffenegger, W. F. Neves-Junior, H. Carvalho, A. D. Pra, F. Moraes
{"title":"Practical considerations of lung stereotactic ablative radiotherapy in the developing world","authors":"D. Asher, P. Munoz-Schuffenegger, W. F. Neves-Junior, H. Carvalho, A. D. Pra, F. Moraes","doi":"10.21037/TRO.2018.12.10","DOIUrl":"https://doi.org/10.21037/TRO.2018.12.10","url":null,"abstract":"Lung cancer is the most common cause of cancer-related death in the world with a disproportionally high burden of disease in low- and middle-income countries (LMICs). Stereotactic ablative radiotherapy (SABR) is the standard of care treatment for inoperable patients with early-stage non-small cell lung cancer (ES-NSCLC) and is currently being evaluated in several randomized control trials in the operable patient setting. SABR for ES-NSCLC has been widely implemented throughout high-income countries (HICs), yet its implementation in LMICs, where the burden of disease is highest, has been limited. The purpose of this report is to provide a practical outline for practitioners to implement SABR for ES-NSCLC while addressing potential barriers that may arise in LMICs. We ultimately aim to describe the essential infrastructure, patient selection, human resources, technical requirements, radiation therapy (RT) planning, RT delivery, patient follow up, quality assurance (QA), and cost considerations required to effectively and safely deliver SABR for ES-NSCLC.","PeriodicalId":93236,"journal":{"name":"Therapeutic radiology and oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/TRO.2018.12.10","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46784628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Stereotactic ablative radiation therapy for operable early-stage lung cancer—considerations and controversies 立体定向消融放射治疗早期可手术肺癌的思考与争议
Therapeutic radiology and oncology Pub Date : 2019-01-01 DOI: 10.21037/TRO.2019.01.01
C. Daniels, D. Moghanaki, S. Siva
{"title":"Stereotactic ablative radiation therapy for operable early-stage lung cancer—considerations and controversies","authors":"C. Daniels, D. Moghanaki, S. Siva","doi":"10.21037/TRO.2019.01.01","DOIUrl":"https://doi.org/10.21037/TRO.2019.01.01","url":null,"abstract":"Stereotactic ablative radiation therapy (SABR) is the current standard of care for patients with stage I non-small cell lung cancer (NSCLC) who are not fit for surgery or who refuse an operation. The available evidence suggests that SABR is effective in obtaining durable local control in operable patients as well, but whether it can currently be recommended as an alternative to surgery in this population is contentious because of the absence of high quality long-term prospective randomized survival data. Retrospective comparisons of SABR with surgery are available, but have been subject to bias from the confounding effect of operability. Previous attempts to prospectively compare SABR with surgery in a randomized fashion have been unsuccessful due to poor accrual. From these efforts, the randomized data from two of these prematurely closed trials were combined to explore the potential outcome if they had completed accrual, though the analyses were largely dismissed by the academic community. In this review, we give a critical overview of the available data in this context, and address key areas of controversy which include the questioned importance of pathologic staging of the mediastinum, the appropriate thresholds for empiric treatment of suspicious lung nodules without biopsy confirmation, and the challenges of post-treatment surveillance of the irradiated lung. We also address design considerations aimed at maximising enrolment into ongoing prospective phase III trials of SABR versus surgery.","PeriodicalId":93236,"journal":{"name":"Therapeutic radiology and oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/TRO.2019.01.01","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44599978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Certainty versus practicality: when is histologic proof needed prior to stereotactic ablative radiotherapy for solitary pulmonary nodules? 确定性与实用性:孤立性肺结节立体定向消融放疗前何时需要组织学证明?
Therapeutic radiology and oncology Pub Date : 2019-01-01 DOI: 10.21037/TRO.2019.01.02
A. Arifin, A. Louie
{"title":"Certainty versus practicality: when is histologic proof needed prior to stereotactic ablative radiotherapy for solitary pulmonary nodules?","authors":"A. Arifin, A. Louie","doi":"10.21037/TRO.2019.01.02","DOIUrl":"https://doi.org/10.21037/TRO.2019.01.02","url":null,"abstract":"Stereotactic ablative radiotherapy (SABR) is a radiotherapy technique for treating early-stage non-small cell lung cancer (NSCLC), and is characterized by high dose per fraction, few fractions, and image-guided precision. Multiple studies have consistently demonstrated high rates of local control and a low incidence of serious adverse events, making it an attractive option for patients who are medically unfit for surgery. Although a biopsy is recommended for confirmation of the diagnosis prior to treatment, it is not without its risks. Herein we review the necessity of a biopsy prior to SABR for a solitary pulmonary nodule (SPN) suspicious for early-stage NSCLC. We examine malignancy prediction tools for assessing SPNs and scenarios in which forgoing a biopsy could be reasonable.","PeriodicalId":93236,"journal":{"name":"Therapeutic radiology and oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/TRO.2019.01.02","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43905354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combining hypofractionated radiation therapy with immunotherapy for anorectal malignant melanoma: a case report 低分割放疗与免疫疗法联合治疗肛门直肠恶性黑色素瘤1例
Therapeutic radiology and oncology Pub Date : 2019-01-01 DOI: 10.21037/TRO.2018.12.09
Wei-Jun Wang, Kuan-Der Lee, Wei-Yu Chen, J. Chiou, Long-Sheng Lu
{"title":"Combining hypofractionated radiation therapy with immunotherapy for anorectal malignant melanoma: a case report","authors":"Wei-Jun Wang, Kuan-Der Lee, Wei-Yu Chen, J. Chiou, Long-Sheng Lu","doi":"10.21037/TRO.2018.12.09","DOIUrl":"https://doi.org/10.21037/TRO.2018.12.09","url":null,"abstract":"A 69-year-old man was diagnosed stage II anorectal malignant melanoma. He received radiotherapy which consisted of 25 Gy in 5 fractions to primary lesions and whole pelvis. He started pembrolizumab 3 weeks after the completion of radiotherapy. The treatment was complicated by CTCAE v4.0 grade 3 diarrhea. Ten weeks after radiotherapy, near total regression of the primary lesion as well as lymph nodes were found. The patient continued triweekly pembrolizumab and local recurrence was noted at 9 months after the initial diagnosis. Treating anorectal malignant melanoma with radiation assisted immunotherapy is worth considering and further study is warranted.","PeriodicalId":93236,"journal":{"name":"Therapeutic radiology and oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/TRO.2018.12.09","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44461229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Is radiotherapy the missing link to enhancing the outcomes in non-small cell lung cancer patients treated with immunotherapy? 放疗是增强免疫治疗非小细胞肺癌患者预后的缺失环节吗?
Therapeutic radiology and oncology Pub Date : 2018-12-01 DOI: 10.21037/tro.2018.12.08
R. Dams, D. Raben, Percy Lee
{"title":"Is radiotherapy the missing link to enhancing the outcomes in non-small cell lung cancer patients treated with immunotherapy?","authors":"R. Dams, D. Raben, Percy Lee","doi":"10.21037/tro.2018.12.08","DOIUrl":"https://doi.org/10.21037/tro.2018.12.08","url":null,"abstract":"Significant improvements in outcomes for locally advanced and metastatic non-small cell lung cancer (NSCLC) have been seen with increased use of immune checkpoint inhibitors (ICIs), and their role in the treatment of early-stage NSCLC is a subject of active investigation. Mounting evidence from preclinical and clinical trials involving immunotherapy for NSCLC has demonstrated the importance of understanding the tumor microenvironment (TME) and the host anti-tumor response. Incorporation of radiation, specifically in hypofractionated regimens, may potentiate the anti-tumor response stimulated by ICIs and thereby improve the efficacy of immunotherapy for these patients. Additional studies are in progress to determine the optimal sequence, dose, fractionation, and duration of combination therapy.","PeriodicalId":93236,"journal":{"name":"Therapeutic radiology and oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44812398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving regional dose distribution while maintaining high delivery efficiency for hypofractionated whole breast radiotherapy 低分割全乳放疗在保持高递送效率的同时，改善区域剂量分布
Therapeutic radiology and oncology Pub Date : 2018-12-01 DOI: 10.21037/TRO.2018.11.01
Lijun Ma, A. Hwang
{"title":"Improving regional dose distribution while maintaining high delivery efficiency for hypofractionated whole breast radiotherapy","authors":"Lijun Ma, A. Hwang","doi":"10.21037/TRO.2018.11.01","DOIUrl":"https://doi.org/10.21037/TRO.2018.11.01","url":null,"abstract":"Skin toxicities, particularly in the inframammary fold areas are noted for patients receiving hypofractionated whole breast radiation therapy. In this study, a hybrid modulated beam technique was developed to tackle such a problem. The technique aimed to achieve significant dose improvements to the inframammary region while maintaining the robustness and treatment delivery efficiency similar to that of 3D conformal treatment delivery. The overall treatment time for the technique was about 6 minutes or less for a treatment session delivering a fractional dose of 266 cGy. As a result, clinical centers with a high volume of patients are most likely to benefit from implementing such a technique.","PeriodicalId":93236,"journal":{"name":"Therapeutic radiology and oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43319071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信